These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31332837)

  • 1. FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.
    Collins B; Kypridemos C; Pearson-Stuttard J; Huang Y; Bandosz P; Wilde P; Kersh R; Capewell S; Mozaffarian D; Whitsel LP; Micha R; O'Flaherty M;
    Milbank Q; 2019 Sep; 97(3):858-880. PubMed ID: 31332837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.
    Pearson-Stuttard J; Kypridemos C; Collins B; Mozaffarian D; Huang Y; Bandosz P; Capewell S; Whitsel L; Wilde P; O'Flaherty M; Micha R
    PLoS Med; 2018 Apr; 15(4):e1002551. PubMed ID: 29634725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.
    Huang Y; Kypridemos C; Liu J; Lee Y; Pearson-Stuttard J; Collins B; Bandosz P; Capewell S; Whitsel L; Wilde P; Mozaffarian D; O'Flaherty M; Micha R;
    Circulation; 2019 Jun; 139(23):2613-2624. PubMed ID: 30982338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis.
    Nilson EAF; Pearson-Stuttard J; Collins B; Guzman-Castillo M; Capewell S; O'Flaherty M; Jaime PC; Kypridemos C
    BMC Med; 2021 Sep; 19(1):225. PubMed ID: 34583695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Impact and Cost-Effectiveness of Volume, Tiered, and Absolute Sugar Content Sugar-Sweetened Beverage Tax Policies in the United States: A Microsimulation Study.
    Lee Y; Mozaffarian D; Sy S; Liu J; Wilde PE; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2020 Aug; 142(6):523-534. PubMed ID: 32564614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.
    Nghiem N; Blakely T; Cobiac LJ; Cleghorn CL; Wilson N
    BMC Public Health; 2016 May; 16():423. PubMed ID: 27216490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling health gains and cost savings for ten dietary salt reduction targets.
    Wilson N; Nghiem N; Eyles H; Mhurchu CN; Shields E; Cobiac LJ; Cleghorn CL; Blakely T
    Nutr J; 2016 Apr; 15():44. PubMed ID: 27118548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.
    Lee Y; Mozaffarian D; Sy S; Huang Y; Liu J; Wilde PE; Abrahams-Gessel S; Jardim TSV; Gaziano TA; Micha R
    PLoS Med; 2019 Mar; 16(3):e1002761. PubMed ID: 30889188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
    Collins M; Mason H; O'Flaherty M; Guzman-Castillo M; Critchley J; Capewell S
    Value Health; 2014 Jul; 17(5):517-24. PubMed ID: 25128044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study.
    Trieu K; Coyle DH; Afshin A; Neal B; Marklund M; Wu JHY
    PLoS Med; 2021 Oct; 18(10):e1003806. PubMed ID: 34699528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US.
    Du M; Griecci CF; Cudhea FF; Eom H; Kim DD; Wilde P; Wong JB; Wang YC; Michaud DS; Mozaffarian D; Zhang F;
    JAMA Netw Open; 2021 Apr; 4(4):e217501. PubMed ID: 33904914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of a National Sugar-Sweetened Beverage Tax to Reduce Cancer Burdens and Disparities in the United States.
    Du M; Griecci CF; Kim DD; Cudhea F; Ruan M; Eom H; Wong JB; Wilde PE; Michaud DS; Lee Y; Micha R; Mozaffarian D; Zhang FF
    JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa073. PubMed ID: 33409452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Product Reformulation in Response to the Health Star Rating Food Labelling System in Australia.
    Mantilla Herrera AM; Crino M; Erskine HE; Sacks G; Ananthapavan J; Mhurchu CN; Lee YY
    Nutrients; 2018 May; 10(5):. PubMed ID: 29757979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.